Bill and Melinda Gates Foundation/Wellcome/Mastercard/Chan Zuckerberg Initiative

COVID 19 Therapeutics Accelerator - $150 million: The funding will help strengthen detection, isolation and treatment efforts; protect at-risk populations; and develop vaccines, treatments and diagnostics. The R&D efforts are focused on developing new drugs, as well as exploring the possibilities to repurpose existing medicines. This work will leverage the power of partnership to develop, manufacture, and distribute effective treatments—and quickly. The COVID-19 Therapeutics Accelerator will not be conducting a traditional funding call. To learn more about the funding process, or how to invest in the accelerator, contact epidemics@wellcome.ac.uk (opens in a new tab).
The COVID-19 Therapeutics Accelerator will work closely with the World Health Organization, government and private sector funders, and global regulatory and policy-setting institutions. It will have an end-to-end focus – from drug pipeline development through to manufacturing and scale-up – and will provide fast and flexible funding at key stages of the process.